OME Документы SEC - Omega Protein Corp.- Годовой отчет, доверенное заявление, проспект эмиссии

Основная статистика

CIK

1053650

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Omega Protein Corp.

SEC Filings (Chronological Order)

На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.

February 9, 2018	SC 13G/A	OME / Omega Protein Corp. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 18)* OMEGA PROTEIN CORP (Name of Issuer) Common Stock (Title of Class of Securities) 68210P107 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch
February 9, 2018	SC 13G/A	OME / Omega Protein Corp. / Man Group plc - OMEGA PROTEIN CORPORATION Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Omega Protein Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 68210P107 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursu
January 2, 2018	15-12B	OME / Omega Protein Corp. FORM 15-12B ome201712211512b.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-14003 OMEGA PROTEIN CORPORATION (Exact name of reg
December 22, 2017	S-8 POS	OME / Omega Protein Corp. FORM S-8 POS ome20171221cs8pos.htm As filed with the Securities and Exchange Commission on December 22, 2017 Registration No. 333-43498 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-43498 UNDER THE SECURITIES ACT OF 1933 OMEGA PROTEIN CORPORATION (Exact name of registrant as specified in its charter) Nevada 76-0
December 22, 2017	S-8 POS	OME / Omega Protein Corp. FORM S-8 POS ome20171221bs8pos.htm As filed with the Securities and Exchange Commission on December 22, 2017 Registration No. 333-205172 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-205172 UNDER THE SECURITIES ACT OF 1933 OMEGA PROTEIN CORPORATION (Exact name of registrant as specified in its charter) Nevada 76
December 22, 2017	S-8 POS	OME / Omega Protein Corp. FORM S-8 POS ome20171221s8pos.htm As filed with the Securities and Exchange Commission on December 22, 2017 Registration No. 333-135251 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-135251 UNDER THE SECURITIES ACT OF 1933 OMEGA PROTEIN CORPORATION (Exact name of registrant as specified in its charter) Nevada 76-
December 22, 2017	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events, Submission of Matters to a Vote of Security Holders ome20171221b8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 19, 2017 OMEGA PROTEIN CORPORATION (Exact Name of Registrant as Specified in its Charter) Nevada 001-14003 76-0562134 (State or Other Jurisdiction of Incor
December 22, 2017	EX-99.1	Cooke Inc. acquires Omega Protein Corporation ex102399.htm Exhibit 99.1 Cooke Inc. acquires Omega Protein Corporation SAINT JOHN, NEW BRUNSWICK, CANADA and HOUSTON, TEXAS, USA ? December 19, 2017 ? Cooke Inc. (?Cooke?), a New Brunswick company and parent of Cooke Aquaculture Inc., today announced the completion of its acquisition of Omega Protein Corporation (NYSE: OME) (?Omega Protein?), a nutritional product company and a leading integrated
December 22, 2017	EX-3.1	Amended and Restated Articles of Incorporation of Omega Protein Corporation EX-3.1 2 ex102423.htm EXHIBIT 3.1 Exhibit 3.1 AMENDED AND RESTATED ARTICLES OF INCORPORATION OF OMEGA PROTEIN CORPORATION The undersigned, being the Chief Legal Officer of Omega Protein Corporation (the “Corporation”), hereby declares and certifies as required by Sections 78.385 and 78.390 of the Nevada Revised Statutes that the following facts are true: ONE: The date of filing of the original Art
December 22, 2017	EX-3.2	Amended and Restated Bylaws of Omega Protein Corporation EX-3.2 3 ex102424.htm EXHIBIT 3.2 Exhibit 3.2 BYLAWS Alpha MergerSub, Inc. A Nevada Corporation ARTICLE I Identification Section 1. Name. The name of the Corporation is “Alpha MergerSub, Inc.” Section 2. Principal Office. The principal office of the Corporation shall be located at 40 Wellington Row, Saint John, N.B., Canada, E2L 3H3. The Board of Directors shall have the power and discretion to ch
December 21, 2017	SC 13D/A	OME / Omega Protein Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Omega Protein Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 68210P107 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Numb
December 20, 2017	EX-99.25	EX-99.25 NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on January 2, 2018, pursuant to the provisions of Rule 12d2-2 (a).
December 13, 2017	SC 13D/A	OME / Omega Protein Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Omega Protein Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 68210P107 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Numb
November 27, 2017	EX-99.1	Omega Protein Announces Date for Special Meeting to Approve Merger ex101071.htm Exhibit 99.1 Omega Protein Announces Date for Special Meeting to Approve Merger HOUSTON, November 27, 2017 ? Omega Protein Corporation (NYSE: OME) (the ?Company?) announced today that the special meeting of stockholders (the ?Special Meeting?) in connection with the proposed merger with Cooke Inc. (?Cooke?) will be held on December 19, 2017 at 9:00 a.m. Central Time at First City Towe
November 27, 2017	8-K	Regulation FD Disclosure, Other Events 8-K 1 ome201711248k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 27, 2017 OMEGA PROTEIN CORPORATION (Exact Name of Registrant as Specified in Charter) Nevada 001-14003 76-0562134 (State or Other Jurisdictio
November 27, 2017	DEFA14A	OME / Omega Protein Corp. FORM 8-K ome201711248k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 27, 2017 OMEGA PROTEIN CORPORATION (Exact Name of Registrant as Specified in Charter) Nevada 001-14003 76-0562134 (State or Other Jurisdiction of Incorporat
November 27, 2017	EX-99.1	Press release of Omega Protein Corporation dated November 27, 2017. EX-99.1 2 ex101071.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Announces Date for Special Meeting to Approve Merger HOUSTON, November 27, 2017 – Omega Protein Corporation (NYSE: OME) (the “Company”) announced today that the special meeting of stockholders (the “Special Meeting”) in connection with the proposed merger with Cooke Inc. (“Cooke”) will be held on December 19, 2017 at 9:00 a.m. Central
November 24, 2017	DEFM14A	OME / Omega Protein Corp. FORM DEFM14A ex96370.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive
November 13, 2017	EX-99.1	Omega Protein Corporation Announces Record Date for Special Meeting EX-99.1 2 ex100452.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Corporation Announces Record Date for Special Meeting HOUSTON, November 13, 2017 – Omega Protein Corporation (NYSE: OME) (the “Company”) announced today that Company stockholders of record at the close of business on November 24, 2017 will be entitled to receive notice of and to vote at a special meeting of Company stockholders (the “S
November 13, 2017	8-K	Other Events 8-K 1 ome201711138k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 13, 2017 OMEGA PROTEIN CORPORATION (Exact Name of Registrant as Specified in Charter) Nevada 001-14003 76-0562134 (State or Other Jurisdictio
November 13, 2017	EX-99.1	Press release of Omega Protein Corporation dated November 13, 2017. EX-99.1 2 ex100452.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Corporation Announces Record Date for Special Meeting HOUSTON, November 13, 2017 – Omega Protein Corporation (NYSE: OME) (the “Company”) announced today that Company stockholders of record at the close of business on November 24, 2017 will be entitled to receive notice of and to vote at a special meeting of Company stockholders (the “S
November 13, 2017	DEFA14A	OME / Omega Protein Corp. FORM 8-K ome201711138k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 13, 2017 OMEGA PROTEIN CORPORATION (Exact Name of Registrant as Specified in Charter) Nevada 001-14003 76-0562134 (State or Other Jurisdiction of Incorporat
November 13, 2017	SC 13D/A	OME / Omega Protein Corp. / Radoff Bradley Louis - AMENDMENT NO. 1 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 Omega Protein Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 68210P107 (CUSIP Number) GREG LEMPEL
November 13, 2017	SC 13D	OME / Omega Protein Corp. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Omega Protein Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 68210P107 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Autho
November 8, 2017	EX-99.1	Omega Protein Announces Third Quarter 2017 Financial Results ex99673.htm Exhibit 99.1 Omega Protein Announces Third Quarter 2017 Financial Results HOUSTON, TX – November 8, 2017 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today reported financial results for the third quarter and nine months ended September 30, 2017. Third Quarter 2017 Highlights ●
November 8, 2017	8-K	Results of Operations and Financial Condition 8-K 1 ome201711068k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): November 8, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-140
November 8, 2017	10-Q	OME / Omega Protein Corp. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to . Commission file number: 001-14003 OMEGA PROT
October 30, 2017	PREM14A	Omega Protein FORM PREM14A ex96370.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive
October 6, 2017	DEFA14A	Omega Protein FORM DEFA14A ome20171005defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6e(2)) ? D
October 6, 2017	EX-10.3	Employment Agreement Amendment of Dr. Mark E. Griffin. ex96364.htm Exhibit 10.3 October 5, 2017 Dr. Mark E. Griffin 2105 City West Blvd., Suite 500 Houston, Texas 77042 Dear Mr. Griffin: This letter amends the Employment Agreement dated as of January 1, 2012 between Omega Protein Corporation (the “Company”) and you (the “Employment Agreement”). Specifically, as of the date hereof, the Employment Agreement is amended as follows: 1. Section 3(d) of the
October 6, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events ome201710058k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 5, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada 001-14003 76-0562134 (State or other jurisdiction of incorpor
October 6, 2017	EX-10.4	Employment Agreement Amendment of Andrew C. Johannesen. EX-10.4 6 ex96365.htm EXHIBIT 10.4 Exhibit 10.4 October 5, 2017 Andrew. C. Johannesen 2105 City West Blvd., Suite 500 Houston, Texas 77042 Dear Mr. Johannesen: This letter amends the Employment Agreement dated as of January 1, 2012 between Omega Protein Corporation (the “Company”) and you (the “Employment Agreement”). Specifically, as of the date hereof, the Employment Agreement is amended as foll
October 6, 2017	EX-99.1	Cooke Inc. Agrees to Acquire Omega Protein Corporation for $22.00 Per Share EX-99.1 9 ex96371.htm EXHIBIT 99.1 Exhibit 99.1 Cooke Inc. Agrees to Acquire Omega Protein Corporation for $22.00 Per Share ● Omega Protein’s Stockholders to Receive $22.00 Per Share in Cash ● Transaction Valued at Approximately $500 Million ● Transaction Represents Key Strategic Addition for the Global Seafood Company SAINT JOHN, NEW BRUNSWICK, CANADA & HOUSTON, TEXAS – October 6, 2017 – Cooke In
October 6, 2017	EX-10.1	Purchase and Sale Agreement by and among Omega Protein Corporation and Alpha VesselCo Holdings, Inc., dated as of October 5, 2017.* ex96372.htm Exhibit 10.1 PURCHASE AND SALE AGREEMENT This PURCHASE AND SALE AGREEMENT, dated as of October 5, 2017 (this ?Agreement?), is entered into by and among Omega Protein Corporation, a Nevada corporation (?Seller?), and Alpha VesselCo Holdings, Inc., a Delaware corporation (?Buyer?). RECITALS WHEREAS, Seller, directly and indirectly through its wholly owned subsidiary, owns all of the MARA
October 6, 2017	EX-10.5	Employment Agreement Amendment of Mark A. Livingston. Exhibit 10.5 October 5, 2017 Mark A. Livingston 2105 City West Blvd., Suite 500 Houston, Texas 77042 Dear Mr. Livingston: This letter amends the Employment Agreement dated as of August 31, 2015 between Omega Protein Corporation (the “Company”) and you (the “Employment Agreement”). Specifically, as of the date hereof, the Employment Agreement is amended as follows: 1. Section 3(d) of the Employment
October 6, 2017	EX-2.1	Agreement and Plan of Merger by and among Omega Protein Corporation, Cooke Inc. and Alpha MergerSub, Inc., dated as of October 5, 2017.* ex_96370.htm Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among COOKE INC., ALPHA MERGERSUB, INC. and OMEGA PROTEIN CORPORATION Dated as of October 5, 2017 TABLE OF CONTENTS PAGE AGREEMENT AND PLAN OF MERGER 1 ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions. 1 Section 1.02 Other Definitional and Interpretative Provisions 10 ARTICLE 2 THE MERGER 10 Section 2.01 The Merger; Effective Time of the
October 6, 2017	EX-10.2	Employment Agreement Amendment of Montgomery C. Deihl. EX-10.2 4 ex96363.htm EXHIBIT 10.2 Exhibit 10.2 October 5, 2017 Montgomery Deihl 2105 City West Blvd., Suite 500 Houston, Texas 77042 Dear Mr. Deihl: This letter amends the Employment Agreement dated as of March 10, 2015 between Omega Protein Corporation (the “Company”) and you (the “Employment Agreement”). Specifically, as of the date hereof, the Employment Agreement is amended as follows: 1. Sec
October 6, 2017	EX-10.6	Employment Agreement Amendment of Bret D. Scholtes. ex96367.htm Exhibit 10.6 October 5, 2017 Bret D. Scholtes 2105 City West Blvd., Suite 500 Houston, Texas 77042 Dear Mr. Scholtes: This letter amends the Employment Agreement dated as of January 1, 2012 between Omega Protein Corporation (the ?Company?) and you (the ?Employment Agreement?). Specifically, as of the date hereof, the Employment Agreement is amended as follows: 1. Section 3(d) of the Em
October 6, 2017	EX-10.1	Purchase and Sale Agreement by and among Omega Protein Corporation and Alpha VesselCo Holdings, Inc., dated as of October 5, 2017.* ex96372.htm Exhibit 10.1 PURCHASE AND SALE AGREEMENT This PURCHASE AND SALE AGREEMENT, dated as of October 5, 2017 (this “Agreement”), is entered into by and among Omega Protein Corporation, a Nevada corporation (“Seller”), and Alpha VesselCo Holdings, Inc., a Delaware corporation (“Buyer”). RECITALS WHEREAS, Seller, directly and indirectly through its wholly owned subsidiary, owns all of the MARA
October 6, 2017	EX-99.1	Joint Press Release dated October 6, 2017 of Omega Protein Corporation and Cooke Inc. EX-99.1 9 ex96371.htm EXHIBIT 99.1 Exhibit 99.1 Cooke Inc. Agrees to Acquire Omega Protein Corporation for $22.00 Per Share ● Omega Protein’s Stockholders to Receive $22.00 Per Share in Cash ● Transaction Valued at Approximately $500 Million ● Transaction Represents Key Strategic Addition for the Global Seafood Company SAINT JOHN, NEW BRUNSWICK, CANADA & HOUSTON, TEXAS – October 6, 2017 – Cooke In
October 6, 2017	EX-2.1	Agreement and Plan of Merger by and among Omega Protein Corporation, Cooke Inc. and Alpha MergerSub, Inc., dated as of October 5, 2017.* EX-2.1 2 ex96370.htm EXHIBIT 2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among COOKE INC., ALPHA MERGERSUB, INC. and OMEGA PROTEIN CORPORATION Dated as of October 5, 2017 TABLE OF CONTENTS PAGE AGREEMENT AND PLAN OF MERGER 1 ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions. 1 Section 1.02 Other Definitional and Interpretative Provisions 10 ARTICLE 2 THE MERGER 10 Section 2.01 The Merger; E
October 6, 2017	EX-10.3	Employment Agreement Amendment of Dr. Mark E. Griffin. EX-10.3 5 ex96364.htm EXHIBIT 10.3 Exhibit 10.3 October 5, 2017 Dr. Mark E. Griffin 2105 City West Blvd., Suite 500 Houston, Texas 77042 Dear Mr. Griffin: This letter amends the Employment Agreement dated as of January 1, 2012 between Omega Protein Corporation (the “Company”) and you (the “Employment Agreement”). Specifically, as of the date hereof, the Employment Agreement is amended as follows:
October 6, 2017	EX-10.2	Employment Agreement Amendment of Montgomery C. Deihl. ex96363.htm Exhibit 10.2 October 5, 2017 Montgomery Deihl 2105 City West Blvd., Suite 500 Houston, Texas 77042 Dear Mr. Deihl: This letter amends the Employment Agreement dated as of March 10, 2015 between Omega Protein Corporation (the ?Company?) and you (the ?Employment Agreement?). Specifically, as of the date hereof, the Employment Agreement is amended as follows: 1. Section 3(d) of the Employ
October 6, 2017	EX-10.4	Employment Agreement Amendment of Andrew C. Johannesen. EX-10.4 6 ex96365.htm EXHIBIT 10.4 Exhibit 10.4 October 5, 2017 Andrew. C. Johannesen 2105 City West Blvd., Suite 500 Houston, Texas 77042 Dear Mr. Johannesen: This letter amends the Employment Agreement dated as of January 1, 2012 between Omega Protein Corporation (the “Company”) and you (the “Employment Agreement”). Specifically, as of the date hereof, the Employment Agreement is amended as foll
October 6, 2017	EX-10.6	Employment Agreement Amendment of Bret D. Scholtes. EX-10.6 8 ex96367.htm EXHIBIT 10.6 Exhibit 10.6 October 5, 2017 Bret D. Scholtes 2105 City West Blvd., Suite 500 Houston, Texas 77042 Dear Mr. Scholtes: This letter amends the Employment Agreement dated as of January 1, 2012 between Omega Protein Corporation (the “Company”) and you (the “Employment Agreement”). Specifically, as of the date hereof, the Employment Agreement is amended as follows: 1.
October 6, 2017	DEFA14A	Omega Protein FORM 8-K ome201710058k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 5, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada 001-14003 76-0562134 (State or other jurisdiction of incorpor
October 6, 2017	EX-10.5	Employment Agreement Amendment of Mark A. Livingston. EX-10.5 7 ex96366.htm EXHIBIT 10.5 Exhibit 10.5 October 5, 2017 Mark A. Livingston 2105 City West Blvd., Suite 500 Houston, Texas 77042 Dear Mr. Livingston: This letter amends the Employment Agreement dated as of August 31, 2015 between Omega Protein Corporation (the “Company”) and you (the “Employment Agreement”). Specifically, as of the date hereof, the Employment Agreement is amended as follows
August 28, 2017	SC 13D	OME / Omega Protein Corp. / Radoff Bradley Louis - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 Omega Protein Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 68210P107 (CUSIP Number) GREG LEMPEL 1
August 28, 2017	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.01 par value, of Omega Protein Corporation, a Nevada corporation. This J
August 2, 2017	8-K	Results of Operations and Financial Condition ome20170726b8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): August 2, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission F
August 2, 2017	EX-99.1	Omega Protein Announces Second Quarter 2017 Financial Results ex99-1.htm Exhibit 99.1 Omega Protein Announces Second Quarter 2017 Financial Results HOUSTON, TX – August 2, 2017 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today reported financial results for the second quarter and six months ended June 30, 2017. Second Quarter 2017 Highlights ● Revenu
August 2, 2017	10-Q	OME / Omega Protein Corp. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to . Commission file number: 001-14003 OMEGA PROTEIN C
August 1, 2017	EX-99.1	Omega Protein Declares Quarterly Dividend ex99-1.htm Exhibit 99.1 Omega Protein Declares Quarterly Dividend HOUSTON, TX ? August 1, 2017 ? Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, announced today that its Board of Directors has declared a quarterly cash dividend of $0.05 per share. The dividend is payable on September 15, 2017 to
August 1, 2017	8-K	Financial Statements and Exhibits, Other Events ome201707268k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): August 1, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fi
June 30, 2017	EX-24	EX-24 POWER OF ATTORNEY WHEREAS, the undersigned may be required to make filings with the Securities and Exchange Commission (the "Commission") under Section 16 of the Securities Exchange Act of 1934, as amended (the "Act"), and the rules and regulations of the Commission promulgated thereunder, relating to his equity ownership in Omega Protein Corporation (the "Company"); NOW, THEREFORE, the undersigned, in his capacity as a proposed director of the Company, does hereby appoint John D.
June 30, 2017	EX-10.1	OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN (Independent Director) ex10-1.htm Exhibit 10.1 OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN (Independent Director) In this Award, Omega Protein Corporation (the ?Company?) grants to (the ?Participant?), a Director, Restricted Stock under the Omega Protein Corporation 2015 Long Term Incentive Plan (the ?Plan?) as of the Date of Grant written below. This Award of Restricted Stock
June 30, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders ome201706128k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 29, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
June 7, 2017	DEFR14A	Omega Protein FORM DEFR14A ome20170606def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Pr
May 17, 2017	8-K	Regulation FD Disclosure ome201705128k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 17, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
May 17, 2017	EX-99.1	EX-99.1 ex99-1.htm Exhibit 99.1
May 16, 2017	8-K	Other Events ome201705168k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 12, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
May 8, 2017	EX-99.1	Omega Protein Announces First Quarter 2017 Financial Results ex99-1.htm Exhibit 99.1 Omega Protein Announces First Quarter 2017 Financial Results HOUSTON, TX ? May 8, 2017 ? Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today reported financial results for the first quarter ended March 31, 2017. First Quarter 2017 Highlights ? Revenues: $73.6 million, c
May 8, 2017	8-K	Results of Operations and Financial Condition 8-K 1 ome201705028k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 8, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (C
May 8, 2017	10-Q	Omega Protein FORM 10-Q (Quarterly Report) ome2017042810q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to . Commission file number: 001-1
May 1, 2017	EX-99.1	Omega Protein Declares Quarterly Dividend ex99-1.htm Exhibit 99.1 Omega Protein Declares Quarterly Dividend HOUSTON, TX – May 1, 2017 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, announced today that its Board of Directors has declared a quarterly cash dividend of $0.05 per share. The dividend is payable on June 15, 2017 to shareho
May 1, 2017	8-K	Financial Statements and Exhibits, Other Events ome201704208k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 1, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
April 28, 2017	DEF 14A	Omega Protein FORM DEF 14A ome20170418def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Pro
April 19, 2017	EX-99.1	Omega Protein Corporation Board of Directors Nominates Dr. Celeste Clark to Board EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Corporation Board of Directors Nominates Dr. Celeste Clark to Board ● Nominates David Owen for re-election as a director ● Announces Dr. Gary Allee will not stand for re-election HOUSTON, TX – April 19, 2017 – Omega Protein Corporation (NYSE:OME), today announced that its Board of Directors has unanimously nominated Dr. Celeste Clark to
April 19, 2017	8-K	Financial Statements and Exhibits, Other Events 8-K 1 ome201704118k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): April 19, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003
March 22, 2017	8-K	Other Events 8-K 1 ome201703228k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): March 16, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003
March 3, 2017	EX-10.1	OMEGA PROTEIN CORPORATION 2017 CASH INCENTIVE PERFORMANCE UNIT PLAN ex10-1.htm Exhibit 10.1 OMEGA PROTEIN CORPORATION 2017 CASH INCENTIVE PERFORMANCE UNIT PLAN THIS OMEGA PROTEIN CORPORATION 2017 CASH INCENTIVE PERFORMANCE UNIT PLAN (this ?Plan?), is hereby adopted by the Board under and subject to the Omega Protein Corporation 2015 Long Term Incentive Plan (?the 2015 Incentive Plan?), effective as of January 1, 2017 (the ?Effective Date?). 1. Purpose and Performa
March 3, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits ome201702238k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada 001-14003 76-0562134 (State or other jurisdiction of incorp
March 3, 2017	EX-10.2	OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN EX-10.2 3 ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN In this Award, Omega Protein Corporation (the “Company”) grants to [] (the “Participant”), an Employee, Restricted Stock under the Omega Protein Corporation 2015 Long Term Incentive Plan (the “Plan”) as of the Date of Grant written below. This Award of Restricted S
March 1, 2017	EX-99.1	Omega Protein Announces Fourth Quarter and Full Year 2016 Financial Results EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Announces Fourth Quarter and Full Year 2016 Financial Results HOUSTON, TX – March 1, 2017 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today reported financial results for the fourth quarter and full year ended December 31, 2016.
March 1, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 ome20170223b8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): March 1, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003
March 1, 2017	10-K	Omega Protein FORM 10-K (Annual Report) ome2016123110k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-14003 OMEGA
March 1, 2017	EX-21	Omega Protein Corporation owns 100% of the common stock of: EX-21 2 ex21.htm EXHIBIT 21 Exhibit 21 Omega Protein Corporation owns 100% of the common stock of: • Protein Finance Company, a Delaware corporation • Omega Shipyard, Inc., a Delaware corporation • Omega Protein, Inc., a Virginia corporation • Protein Industries, Inc., a Delaware corporation, wholly owned subsidiary • Owns 1% of the equity of Omega Protein Mexico, S. de R. L. de C.V., a Mexican co
February 22, 2017	8-K	Financial Statements and Exhibits, Other Events ome201702208k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): February 22, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission
February 22, 2017	EX-99.1	Omega Protein Commences Strategic Review of Human Nutrition Business Segment to Increase Shareholder Value ex99-1.htm Exhibit 99.1 Omega Protein Commences Strategic Review of Human Nutrition Business Segment to Increase Shareholder Value HOUSTON, TX – February 22, 2017 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today announced that the Company and its Board of Directors have initiated a strate
February 9, 2017	SC 13G	OME / Omega Protein Corp. / FRANKLIN RESOURCES INC Passive Investment SC 13G 1 omeg16in.htm CUSIP NO. 68210P107 13G Page 1 of 14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* OMEGA PROTEIN CORPORATION (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 68210P107 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this State
February 9, 2017	SC 13G/A	OME / Omega Protein Corp. / Man Group plc - MAN GROUP PLC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Omega Protein Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 68210P107 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursu
February 9, 2017	SC 13G/A	OME / Omega Protein Corp. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 16)* OMEGA PROTEIN CORP (Name of Issuer) Common Stock (Title of Class of Securities) 68210P107 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch
January 23, 2017	EX-99.1	Omega Protein Establishes Quarterly Dividend Program Institutes Quarterly Cash Dividend of $0.05 Per Share ex99-1.htm Exhibit 99.1 Omega Protein Establishes Quarterly Dividend Program Institutes Quarterly Cash Dividend of $0.05 Per Share HOUSTON, TX ? January 23, 2017 ? Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, announced today that its Board of Directors has approved the initiation of a dividen
January 23, 2017	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events 8-K 1 ome201701208k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): January 23, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-140
January 23, 2017	EX-99.1	Omega Protein Establishes Quarterly Dividend Program Institutes Quarterly Cash Dividend of $0.05 Per Share ex99-1.htm Exhibit 99.1 Omega Protein Establishes Quarterly Dividend Program Institutes Quarterly Cash Dividend of $0.05 Per Share HOUSTON, TX ? January 23, 2017 ? Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, announced today that its Board of Directors has approved the initiation of a dividen
January 23, 2017	DEFA14A	Omega Protein FORM 8-K ome201701208k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): January 23, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission
January 11, 2017	EX-99.1	EX-99.1 ex99-1.htm Exhibit 99.1
January 11, 2017	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 ome201701058k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): January 11, 2017 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-140
December 16, 2016	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201612128k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (Date of earliest event reported): December 15, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada 001-14003 76-0562134 (State or other jurisdiction of incorp
December 16, 2016	EX-10.1	UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA LAFAYETTE DIVISION ex99-1.htm Exhibit 10.1 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA LAFAYETTE DIVISION UNITED STATES OF AMERICA * CRIMINAL NO. 16-CR-00292 * VERSUS * DISTRICT JUDGE * OMEGA PROTEIN, INC. * MAGISTRATE JUDGE PLEA AGREEMENT A. INTRODUCTION This document contains the complete plea agreement between the Government and OMEGA PROTEIN, INC. (hereinafter referred to as "OMEGA"), the Defendan
November 2, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): November 2, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File Number) 76-05
November 2, 2016	EX-99.1	Omega Protein Announces Third Quarter 2016 Financial Results EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Announces Third Quarter 2016 Financial Results HOUSTON, TX – November 2, 2016 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today reported financial results for the third quarter and nine months ended September 30, 2016. Third Quar
November 2, 2016	10-Q	Omega Protein FORM 10-Q (Quarterly Report) 10-Q 1 ome2016081810q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to . Commissi
October 5, 2016	SC 13G	OME / Omega Protein Corp. / Man Group plc - MAN GROUP PLC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* Omega Protein Corporation (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 68210P107 (CUSIP Number) September 26, 2016 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant
August 26, 2016	SC 13D/A	OME / Omega Protein Corp. / WYNNEFIELD PARTNERS SMALL CAP VALUE LP - SCHEDULE 13D AMENDMENT NO. 8 Activist Investment SC 13D/A 1 v447763sc13da.htm SCHEDULE 13D AMENDMENT NO. 8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 8) Under the Securities Exchange Act of 1934 OMEGA PROTEIN CORPORATION (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 68210P107 (CUSIP Number) Wynnefield Partners Small Cap Value, L.P. 450 Seventh Avenue, Suit
August 16, 2016	SC 13D/A	OME / Omega Protein Corp. / WYNNEFIELD PARTNERS SMALL CAP VALUE LP - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 7) Under the Securities Exchange Act of 1934 OMEGA PROTEIN CORPORATION (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 68210P107 (CUSIP Number) Wynnefield Partners Small Cap Value, L.P. 450 Seventh Avenue, Suite 509 New York, New York 10123 Attention: Mr. Nelson Obus
August 16, 2016	SC 13D/A	OME / Omega Protein Corp. / WYNNEFIELD PARTNERS SMALL CAP VALUE LP - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 7) Under the Securities Exchange Act of 1934 OMEGA PROTEIN CORPORATION (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 68210P107 (CUSIP Number) Wynnefield Partners Small Cap Value, L.P. 450 Seventh Avenue, Suite 509 New York, New York 10123 Attention: Mr. Nelson Obus
August 3, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition ome201607278k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): August 3, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fi
August 3, 2016	EX-99.1	Omega Protein Announces Second Quarter 2016 Financial Results EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Announces Second Quarter 2016 Financial Results HOUSTON, TX – August 3, 2016 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today reported financial results for the second quarter and six months ended June 30, 2016. Second Quarter 2
August 3, 2016	10-Q	Omega Protein FORM 10-Q (Quarterly Report) ome2016063010q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to . Commission file number: 001-14
August 3, 2016	EX-10.2	TERMINATION OF LEASE AGREEMENT ex10-2.htm EXHIBIT 10.2 TERMINATION OF LEASE AGREEMENT This TERMINATION OF LEASE AGREEMENT is made and agreed to as of June 9, 2016 (the “Effective Date”) between The Ardoin Limited Partnership, a Louisiana limited partnership (“Lessor”), LR Henry, LLC (“Lessor” and collectively “Lessors”) and Omega Protein, Inc. (fka Zapatie Haynie Corporation) (“Lessee”). RECITALS A. Lessors and Zapata Haynie Co
July 8, 2016	EX-24	EX-24 POWER OF ATTORNEY WHEREAS, the undersigned may be required to make filings with the Securities and Exchange Commission (the "Commission") under Section 16 of the Securities Exchange Act of 1934, as amended (the "Act"), and the rules and regulations of the Commission promulgated thereunder, relating to his equity ownership in Omega Protein Corporation (the "Company"); NOW, THEREFORE, the undersigned, in his capacity as a proposed director of the Company, does hereby appoint John D.
July 1, 2016	EX-10.1	OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN (Independent Director) EX-10.1 2 ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN (Independent Director) In this Award, Omega Protein Corporation (the “Company”) grants to (the “Participant”), a Director, Restricted Stock under the Omega Protein Corporation 2015 Long Term Incentive Plan (the “Plan”) as of the Date of Grant written below. This Aw
July 1, 2016	EX-24	EX-24 POWER OF ATTORNEY WHEREAS, the undersigned may be required to make filings with the Securities and Exchange Commission (the "Commission") under Section 16 of the Securities Exchange Act of 1934, as amended (the "Act"), and the rules and regulations of the Commission promulgated thereunder, relating to his equity ownership in Omega Protein Corporation (the "Company"); NOW, THEREFORE, the undersigned, in his capacity as a proposed director of the Company, does hereby appoint John D.
July 1, 2016	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201606308k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 28, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
June 28, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: ? Filed by a Party other than the Registrant: x Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement x Definitive Additional Materials ? Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
June 28, 2016	EX-99.1	OMEGA ANNOUNCES PRELIMINARY RESULTS OF 2016 ANNUAL MEETING OF STOCKHOLDERS EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 OMEGA ANNOUNCES PRELIMINARY RESULTS OF 2016 ANNUAL MEETING OF STOCKHOLDERS HOUSTON, June 28, 2016 - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today announced the anticipated results of its 2016 annual meeting of stockholders, held June 28 in
June 28, 2016	8-K	Financial Statements and Exhibits, Other Events ome201606278k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 28, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
June 20, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: X Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement X Definitive Additional Materials Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
June 17, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: X Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement X Definitive Additional Materials Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
June 17, 2016	EX-99.1	OMEGA PROTEIN CLARIFIES CRITICAL FACTS FOR STOCKHOLDERS Responds to ISS and Glass Lewis Reports; Encourages Stockholders to Conduct Independent Analysis Vote the WHITE Proxy Card to Support the Board's Candidates for Long-Term Value Creation ex99-1.htm Exhibit 99.1 OMEGA PROTEIN CLARIFIES CRITICAL FACTS FOR STOCKHOLDERS Responds to ISS and Glass Lewis Reports; Encourages Stockholders to Conduct Independent Analysis Vote the WHITE Proxy Card to Support the Board's Candidates for Long-Term Value Creation HOUSTON, June 17, 2016 - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of spe
June 17, 2016	8-K	Financial Statements and Exhibits, Other Events ome201606168k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 17, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
June 17, 2016	EX-99.1	OMEGA PROTEIN CLARIFIES CRITICAL FACTS FOR STOCKHOLDERS Responds to ISS and Glass Lewis Reports; Encourages Stockholders to Conduct Independent Analysis Vote the WHITE Proxy Card to Support the Board's Candidates for Long-Term Value Creation ex99-1.htm Exhibit 99.1 OMEGA PROTEIN CLARIFIES CRITICAL FACTS FOR STOCKHOLDERS Responds to ISS and Glass Lewis Reports; Encourages Stockholders to Conduct Independent Analysis Vote the WHITE Proxy Card to Support the Board's Candidates for Long-Term Value Creation HOUSTON, June 17, 2016 - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of spe
June 17, 2016	DEFA14A	Omega Protein FORM 8-K ome201606168k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 17, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
June 16, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: X Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement X Definitive Additional Materials Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
June 14, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: X Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement X Definitive Additional Materials Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
June 14, 2016	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 14, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File Number) 76-05621
June 14, 2016	EX-99.1	COURT DENIES WYNNEFIELD’S MOTION FOR PRELIMINARY INJUNCTION Annual Meeting to take place as scheduled on June 28, 2016 Vote the WHITE proxy card to support the Board's candidates for long-term value creation ex99-1.htm Exhibit 99.1 COURT DENIES WYNNEFIELD’S MOTION FOR PRELIMINARY INJUNCTION Annual Meeting to take place as scheduled on June 28, 2016 Vote the WHITE proxy card to support the Board's candidates for long-term value creation HOUSTON, June 14, 2016 - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein
June 14, 2016	EX-99.1	COURT DENIES WYNNEFIELD’S MOTION FOR PRELIMINARY INJUNCTION Annual Meeting to take place as scheduled on June 28, 2016 Vote the WHITE proxy card to support the Board's candidates for long-term value creation EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 COURT DENIES WYNNEFIELD’S MOTION FOR PRELIMINARY INJUNCTION Annual Meeting to take place as scheduled on June 28, 2016 Vote the WHITE proxy card to support the Board's candidates for long-term value creation HOUSTON, June 14, 2016 - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils
June 14, 2016	DEFA14A	Omega Protein FORM 8-K ome201606148k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 14, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
June 13, 2016	EX-99.1	Omega Protein Issues Special Bulletin to Stockholders Regarding Wynnefield Capital’s Deficient Proxy Statement Desperate Hedge Fund Now Wants Omega Protein Stockholders to Pay for its Costly and Distracting Proxy Fight and Doesn’t Want Stockholders t EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Issues Special Bulletin to Stockholders Regarding Wynnefield Capital’s Deficient Proxy Statement Desperate Hedge Fund Now Wants Omega Protein Stockholders to Pay for its Costly and Distracting Proxy Fight and Doesn’t Want Stockholders to Have a Say in That Decision Wynnefield’s Misleading Proxy Materials Explicitly Told Stockholders Wynn
June 13, 2016	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 13, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File Number) 76-05621
June 13, 2016	EX-99.1	Omega Protein Issues Special Bulletin to Stockholders Regarding Wynnefield Capital’s Deficient Proxy Statement Desperate Hedge Fund Now Wants Omega Protein Stockholders to Pay for its Costly and Distracting Proxy Fight and Doesn’t Want Stockholders t ex99-1.htm Exhibit 99.1 Omega Protein Issues Special Bulletin to Stockholders Regarding Wynnefield Capital’s Deficient Proxy Statement Desperate Hedge Fund Now Wants Omega Protein Stockholders to Pay for its Costly and Distracting Proxy Fight and Doesn’t Want Stockholders to Have a Say in That Decision Wynnefield’s Misleading Proxy Materials Explicitly Told Stockholders Wynnefield Would “Not Seek
June 13, 2016	DEFA14A	Omega Protein FORM 8-K ome201606138k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 13, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
June 13, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: X Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement X Definitive Additional Materials Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
June 13, 2016	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201606128k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 13, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
June 13, 2016	EX-99.1	OMEGA PROTEIN DETAILS IMPORTANT FACTS FOR STOCKHOLDERS Sets the Record Straight About Omega’s Strong Performance and Stockholder-Friendly Governance Practices Vote the WHITE Proxy Card to Support the Board’s Candidates for Long-Term Value Creation Exhibit 99.1 OMEGA PROTEIN DETAILS IMPORTANT FACTS FOR STOCKHOLDERS Sets the Record Straight About Omega?s Strong Performance and Stockholder-Friendly Governance Practices Vote the WHITE Proxy Card to Support the Board?s Candidates for Long-Term Value Creation HOUSTON, June 13, 2016 ? The Board of Directors of Omega Protein Corporation (NYSE: OME) (the ?Company? or ?Omega Protein?), today released
June 13, 2016	EX-99.1	OMEGA PROTEIN DETAILS IMPORTANT FACTS FOR STOCKHOLDERS Sets the Record Straight About Omega’s Strong Performance and Stockholder-Friendly Governance Practices Vote the WHITE Proxy Card to Support the Board’s Candidates for Long-Term Value Creation EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 OMEGA PROTEIN DETAILS IMPORTANT FACTS FOR STOCKHOLDERS Sets the Record Straight About Omega’s Strong Performance and Stockholder-Friendly Governance Practices Vote the WHITE Proxy Card to Support the Board’s Candidates for Long-Term Value Creation HOUSTON, June 13, 2016 – The Board of Directors of Omega Protein Corporation (NYSE: OME) (the “Company” o
June 13, 2016	DEFA14A	Omega Protein FORM 8-K ome201606128k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 13, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
June 10, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: ? Filed by a Party other than the Registrant: x Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement x Definitive Additional Materials ? Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
June 9, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: X Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement X Definitive Additional Materials Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
June 8, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: x Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement x Definitive Additional Materials ? Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
June 8, 2016	EX-99.1	OMEGA PROTEIN SENDS LETTER TO STOCKHOLDERS Vote the WHITE Proxy Card to Support the Board’s Candidates for Long-Term Value Creation ex99-1.htm Exhibit 99.1 OMEGA PROTEIN SENDS LETTER TO STOCKHOLDERS Vote the WHITE Proxy Card to Support the Board?s Candidates for Long-Term Value Creation HOUSTON, June 8, 2016 ? The Board of Directors of Omega Protein Corporation (NYSE: OME) (the ?Company? or ?Omega Protein?), today issued a letter to stockholders in connection with the Company?s 2016 Annual Meeting scheduled to be held on June
June 8, 2016	8-K	Financial Statements and Exhibits, Other Events ome201606078k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 8, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
June 8, 2016	EX-99.1	OMEGA PROTEIN SENDS LETTER TO STOCKHOLDERS Vote the WHITE Proxy Card to Support the Board’s Candidates for Long-Term Value Creation ex99-1.htm Exhibit 99.1 OMEGA PROTEIN SENDS LETTER TO STOCKHOLDERS Vote the WHITE Proxy Card to Support the Board?s Candidates for Long-Term Value Creation HOUSTON, June 8, 2016 ? The Board of Directors of Omega Protein Corporation (NYSE: OME) (the ?Company? or ?Omega Protein?), today issued a letter to stockholders in connection with the Company?s 2016 Annual Meeting scheduled to be held on June
June 8, 2016	DEFA14A	Omega Protein FORM 8-K ome201606078k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 8, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
June 7, 2016	EX-99.1	EX-99.1 EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1
June 7, 2016	8-K	Financial Statements and Exhibits, Other Events ome201606068k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 7, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
June 7, 2016	EX-99.2	Omega Protein Corporation Wynnefield Demand Letter ex99-2.htm Exhibit 99.2 June 6, 2016 Omega Protein Corporation Wynnefield Demand Letter On Friday, June 3rd, Wynnefield Small Cap Value, L.P. and its affiliates (“Wynnefield”) filed a lawsuit against Omega Protein Corporation (the “Company”) in Nevada state court. To illustrative how frivolous the lawsuit is, the Company shared the following supplemental slide with Institutional Shareholder Servic
June 7, 2016	DEFA14A	Omega Protein FORM 8-K DEFA14A 1 ome201606068k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 7, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-140
June 7, 2016	EX-99.1	EX-99.1 ex99-1.htm Exhibit 99.1
June 7, 2016	EX-99.2	Omega Protein Corporation Wynnefield Demand Letter ex99-2.htm Exhibit 99.2 June 6, 2016 Omega Protein Corporation Wynnefield Demand Letter On Friday, June 3rd, Wynnefield Small Cap Value, L.P. and its affiliates (“Wynnefield”) filed a lawsuit against Omega Protein Corporation (the “Company”) in Nevada state court. To illustrative how frivolous the lawsuit is, the Company shared the following supplemental slide with Institutional Shareholder Servic
June 6, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: X Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement X Definitive Additional Materials Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
June 6, 2016	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201606058k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 6, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
June 6, 2016	EX-99.1	Omega Protein Issues Statement in Response to Frivolous Litigation Tactic by Wynnefield Capital ex99-1.htm Exhibit 99.1 Omega Protein Issues Statement in Response to Frivolous Litigation Tactic by Wynnefield Capital HOUSTON, June 5, 2016 - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today issued the following statement in response to a lawsuit filed on Friday by dissident stockholder
June 6, 2016	DEFA14A	Omega Protein FORM 8-K ome201606058k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 6, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
June 6, 2016	EX-99.1	Omega Protein Issues Statement in Response to Frivolous Litigation Tactic by Wynnefield Capital ex99-1.htm Exhibit 99.1 Omega Protein Issues Statement in Response to Frivolous Litigation Tactic by Wynnefield Capital HOUSTON, June 5, 2016 - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today issued the following statement in response to a lawsuit filed on Friday by dissident stockholder
May 31, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: X Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Sta
May 31, 2016	DEFC14A	Omega Protein DEFC14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: ? Filed by a Party other than the Registrant: x Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Under Rule 14a-12 Omega Protein Corporation (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
May 24, 2016	PRRN14A	Omega Protein PRRN14A PRELIMINARY PROXY STATEMENT—SUBJECT TO COMPLETION, DATED MAY 24, 2016 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.
May 24, 2016	SC 13D/A	OME / Omega Protein Corp. / WYNNEFIELD PARTNERS SMALL CAP VALUE LP - SC 13D/A Activist Investment SC 13D/A 1 v440505sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 6) Under the Securities Exchange Act of 1934 OMEGA PROTEIN CORPORATION ‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ (Name of Issuer) Common Stock, $0.01 par value ‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾
May 23, 2016	DEFC14A	Omega Protein FORM DEFC14A ome20160508pre14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rul
May 23, 2016	EX-99.1	OMEGA PROTEIN URGES STOCKHOLDERS TO PROTECT VALUE OF THEIR INVESTMENT Omega Management Best Positioned to Execute the Board’s Current Plan Efficiently and Effectively Wynnefield Fails to Present Alternative Plan and Qualified Candidate ex99-1.htm Exhibit 99.1 OMEGA PROTEIN URGES STOCKHOLDERS TO PROTECT VALUE OF THEIR INVESTMENT Omega Management Best Positioned to Execute the Board?s Current Plan Efficiently and Effectively Wynnefield Fails to Present Alternative Plan and Qualified Candidate HOUSTON, May 23, 2016 ? The Board of Directors of Omega Protein Corporation (NYSE: OME) (the ?Company? or ?Omega Protein?), today issued a l
May 23, 2016	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome20160522defa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 23, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission
May 23, 2016	EX-99.1	OMEGA PROTEIN URGES STOCKHOLDERS TO PROTECT VALUE OF THEIR INVESTMENT Omega Management Best Positioned to Execute the Board’s Current Plan Efficiently and Effectively Wynnefield Fails to Present Alternative Plan and Qualified Candidate EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 OMEGA PROTEIN URGES STOCKHOLDERS TO PROTECT VALUE OF THEIR INVESTMENT Omega Management Best Positioned to Execute the Board’s Current Plan Efficiently and Effectively Wynnefield Fails to Present Alternative Plan and Qualified Candidate HOUSTON, May 23, 2016 – The Board of Directors of Omega Protein Corporation (NYSE: OME) (the “Company” or “Omega Prot
May 23, 2016	DEFA14A	Omega Protein FORM 8-K DEFA14A 1 ome201605228k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 23, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-140
May 20, 2016	PREC14A	Omega Protein PREC14A PRELIMINARY PROXY STATEMENT?SUBJECT TO COMPLETION, DATED MAY 20, 2016 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: ? Filed by a Party other than the Registrant: x Check the appropriate box: x Preliminary Proxy Statement ? Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Under Rule 14a-12 Omega Protein Corporation (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
May 19, 2016	DFAN14A	Omega Protein DFAN 14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: X Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials X Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
May 19, 2016	PREC14A	Omega Protein FORM PREC14A ome20160508pre14a.htm PRELIMINARY PROXY STATEMENT?SUBJECT TO COMPLETION, DATED MAY 18, 2016 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Stateme
May 18, 2016	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201605168k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 18, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
May 18, 2016	EX-99.1	EX-99.1 Exhibit 99.1
May 18, 2016	CORRESP	Omega Protein ESP Kai H. Liekefett [email protected] Tel +1.212.237.0037 Fax +1.713.237.0100 May 18, 2016 Via EDGAR, Email and Federal Express Bryan J. Pitko Attorney Advisor Office of Mergers and Acquisitions United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3561 Re: Omega Protein Corporation Preliminary Proxy Statement filed on Schedule 1
May 12, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: Filed by a Party other than the Registrant: X Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials X Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
May 9, 2016	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201605098k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 9, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
May 9, 2016	EX-99.1	Omega Protein Sends Letter to Stockholders Highlighting Strong Performance Under Current Strategy Board’s Director Nominees Qualified to Oversee Strategic Plan, Demonstrate Board’s Commitment to Sound Corporate Governance Practices Announces Nominati ex99-1.htm Exhibit 99.1 Omega Protein Sends Letter to Stockholders Highlighting Strong Performance Under Current Strategy Board?s Director Nominees Qualified to Oversee Strategic Plan, Demonstrate Board?s Commitment to Sound Corporate Governance Practices Announces Nomination of one of Wynnefield?s Board Candidates Despite Wynnefield?s Refusal to Agree to Customary Settlement Terms HOUSTON, May 9,
May 9, 2016	EX-99.1	Omega Protein Sends Letter to Stockholders Highlighting Strong Performance Under Current Strategy Board?s Director Nominees Qualified to Oversee Strategic Plan, Demonstrate Board?s Commitment to Sound Corporate Governance Practices Announces Nominati EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Sends Letter to Stockholders Highlighting Strong Performance Under Current Strategy Board’s Director Nominees Qualified to Oversee Strategic Plan, Demonstrate Board’s Commitment to Sound Corporate Governance Practices Announces Nomination of one of Wynnefield’s Board Candidates Despite Wynnefield’s Refusal to Agree to Customary Settlemen
May 9, 2016	DEFA14A	Omega Protein FORM 8-K ome201605098k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 9, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
May 9, 2016	PREC14A	Omega Protein FORM PREC14A ome20160508pre14a.htm PRELIMINARY PROXY STATEMENT?SUBJECT TO COMPLETION, DATED MAY 9, 2016 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statemen
May 4, 2016	EX-99.1	Omega Protein Announces First Quarter 2016 Financial Results EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Announces First Quarter 2016 Financial Results HOUSTON, TX – May 4, 2016 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today reported financial results for the first quarter ended March 31, 2016. First Quarter 2016 Highlights ● Rev
May 4, 2016	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201605038k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 4, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
May 4, 2016	EX-99.2	Omega Protein Completes Previously Announced Strategic Review; Announces Authorization of $40 Million Share Repurchase Program ex99-2.htm Exhibit 99.2 Omega Protein Completes Previously Announced Strategic Review; Announces Authorization of $40 Million Share Repurchase Program Strategic Review Determines Current Strategy to be Best Path to Maximizing Stockholder Value HOUSTON, May 4, 2016 /PRNewswire/ - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils
May 4, 2016	EX-99.2	Omega Protein Completes Previously Announced Strategic Review; Announces Authorization of $40 Million Share Repurchase Program ex99-2.htm Exhibit 99.2 Omega Protein Completes Previously Announced Strategic Review; Announces Authorization of $40 Million Share Repurchase Program Strategic Review Determines Current Strategy to be Best Path to Maximizing Stockholder Value HOUSTON, May 4, 2016 /PRNewswire/ - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils
May 4, 2016	DEFA14A	Omega Protein FORM 8-K ome201605038k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 4, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
May 4, 2016	EX-99.1	Omega Protein Announces First Quarter 2016 Financial Results EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Announces First Quarter 2016 Financial Results HOUSTON, TX – May 4, 2016 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today reported financial results for the first quarter ended March 31, 2016. First Quarter 2016 Highlights ● Rev
May 4, 2016	10-Q	Omega Protein FORM 10-Q (Quarterly Report) 10-Q 1 ome2016033110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to . Commission f
May 2, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: ? Filed by a Party other than the Registrant: x Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials x Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
April 29, 2016	10-K/A	OME / Omega Protein Corp. 10-K/A - Annual Report - FORM 10-K/A ome2016042710ka.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No. 1 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe
April 28, 2016	DFAN14A	SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: ¨ Filed by a Party other than the Registrant: x Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement ¨ Definitive Additional Materials x Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
April 28, 2016	SC 13D/A	OME / Omega Protein Corp. / WYNNEFIELD PARTNERS SMALL CAP VALUE LP I - SC 13D/A Activist Investment SC 13D/A 1 v437639sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 5) Under the Securities Exchange Act of 1934 OMEGA PROTEIN CORPORATION (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 68210P107 ( CUSIP Number) Wynnefield Partners Small Cap Value, L.P. I 450 Seventh Avenue, Suite 509 New York, N
April 28, 2016	EX-99.2	Wynnefield Calls on Omega to Immediately Set Date for the Annual Meeting Increases Ownership Stake in Omega Protein EX-99.2 2 v437639ex99-2.htm PRESS RELEASE, DATED APRIL 28, 2016 Exhibit 2 Wynnefield Calls on Omega to Immediately Set Date for the Annual Meeting Increases Ownership Stake in Omega Protein NEW YORK – April 28, 2016 – Wynnefield Capital, Inc. and its affiliates (collectively, “Wynnefield”), long-term stockholders of Omega Protein Corp. (NYSE: OME) (“Omega” or the “Company”) with an approximate 7.9
March 30, 2016	SC 13D/A	OME / Omega Protein Corp. / WYNNEFIELD PARTNERS SMALL CAP VALUE LP I - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 4) Under the Securities Exchange Act of 1934 OMEGA PROTEIN CORPORATION (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 68210P107 ( CUSIP Number) Wynnefield Partners Small Cap Value, L.P. I 450 Seventh Avenue, Suite 509 New York, New York 10123 Attention: Mr. Nelson Ob
March 11, 2016	EX-10.1	OMEGA PROTEIN CORPORATION 2016 CASH INCENTIVE PERFORMANCE UNIT PLAN ex10-1.htm EXHIBIT 10.1 OMEGA PROTEIN CORPORATION 2016 CASH INCENTIVE PERFORMANCE UNIT PLAN THIS OMEGA PROTEIN CORPORATION 2016 CASH INCENTIVE PERFORMANCE UNIT PLAN (this “Plan”), is hereby adopted by the Board under and subject to the Omega Protein Corporation 2015 Long Term Incentive Plan (“the 2015 Incentive Plan”), effective as of January 1, 2016 (the “Effective Date”). 1. Purpose and Performa
March 11, 2016	EX-10.2	OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN ex10-2.htm EXHIBIT 10.2 OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN In this Award, Omega Protein Corporation (the ?Company?) grants to [name] (the ?Participant?), an Employee, Restricted Stock under the Omega Protein Corporation 2015 Long Term Incentive Plan (the ?Plan?) as of the Date of Grant written below. This Award of Restricted Stock is governed by
March 11, 2016	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201603108k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): March 8, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
March 11, 2016	DFAN14A	Omega Protein DFAN14A SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant: ? Filed by a Party other than the Registrant: x Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials x Soliciting Material Under Rule 14a-12 OMEGA PROTEIN CORPORATION (Name of Registrant as Specified in its Charter) WYNNEFIELD PARTNERS SMALL CAP VALUE, L.
March 9, 2016	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201603038k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): March 9, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
March 9, 2016	EX-99.1	Omega Protein Announces Fourth Quarter and Full Year 2015 Financial Results ex99-1.htm Exhibit 99.1 Omega Protein Announces Fourth Quarter and Full Year 2015 Financial Results HOUSTON, TX ? March 9, 2016 ? Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today reported financial results for the fourth quarter and year ended December 31, 2015. Fourth Quarter and Full Year
March 9, 2016	10-K	Omega Protein FORM 10-K (Annual Report) ome2015123110k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-14003 OMEGA
March 9, 2016	EX-21	Omega Protein Corporation owns 100% of the common stock of: ex21.htm Exhibit 21 Omega Protein Corporation owns 100% of the common stock of: • Protein Finance Company, a Delaware corporation • Omega Shipyard, Inc., a Delaware corporation • Omega Protein, Inc., a Virginia corporation • Protein Industries, Inc., a Delaware corporation, wholly owned subsidiary • Owns 1% of the equity of Omega Protein Mexico S. de R. L. de C.V., a Mexican corporation (“Omega Pr
March 1, 2016	8-K	Financial Statements and Exhibits, Other Events ome201602298k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada 001-14003 76-0562134 (State or other jurisdiction of incorporat
March 1, 2016	EX-99.1	Omega Protein Issues Statement in Response to Wynnefield Capital’s Notice of Director Nominations ex99-1.htm Exhibit 99.1 Omega Protein Issues Statement in Response to Wynnefield Capital?s Notice of Director Nominations HOUSTON, March 1, 2016 - Omega Protein Corporation (NYSE: OME) (the ?Company? or ?Omega Protein?), a nutritional product company and a leading integrated provider of specialty oils, essential fatty acids and specialty protein products, today issued a statement in response to a
March 1, 2016	EX-99.1	Omega Protein Issues Statement in Response to Wynnefield Capital’s Notice of Director Nominations ex99-1.htm Exhibit 99.1 Omega Protein Issues Statement in Response to Wynnefield Capital’s Notice of Director Nominations HOUSTON, March 1, 2016 - Omega Protein Corporation (NYSE: OME) (the “Company” or “Omega Protein”), a nutritional product company and a leading integrated provider of specialty oils, essential fatty acids and specialty protein products, today issued a statement in response to a
March 1, 2016	DEFA14A	Omega Protein FORM 8-K ome201602298k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2016 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada 001-14003 76-0562134 (State or other jurisdiction of incorporat
March 1, 2016	SC 13D/A	OME / Omega Protein Corp. / WYNNEFIELD PARTNERS SMALL CAP VALUE LP I - SC 13D/A Activist Investment SC 13D/A 1 v432871sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 3) Under the Securities Exchange Act of 1934 OMEGA PROTEIN CORPORATION (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 68210P107 ( CUSIP Number) Wynnefield Partners Small Cap Value, L.P. I 450 Seventh Avenue, Suite 509 New York, N
February 9, 2016	SC 13G/A	Omega Protein SCHEDULE 13G/A (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 16)* OMEGA PROTEIN CORP (Name of Issuer) Common Stock (Title of Class of Securities) 68210P107 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch
February 9, 2016	SC 13G/A	Omega Protein 3G/A (Passive Acquisition of More Than 5% of Shares) omeg15a4.htm - Generated by SEC Publisher for SEC Filing CUSIP NO. 68210P107 13G Page 1 of 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* OMEGA PROTEIN CORPORATION (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 68210P107 (CUSIP Number) December 31, 2015 (Date of Even
November 23, 2015	SC 13D/A	OME / Omega Protein Corp. / Schechter Joshua - AMENDMENT NO. 2 TO THE SCHEDULE 13D Activist Investment SC 13D/A 1 sc13da20907600911232015.htm AMENDMENT NO. 2 TO THE SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 2)1 Omega Protein Corporation (Name of Issuer) Common Stock, $0.01 par value per
November 17, 2015	SC 13D/A	OME / Omega Protein Corp. / WYNNEFIELD PARTNERS SMALL CAP VALUE LP I - SC 13D/A Activist Investment SC 13D/A 1 v425023sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 2) Under the Securities Exchange Act of 1934 OMEGA PROTEIN CORPORATION ‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ (Name of Issuer) Common Stock, $0.01 par value ‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾
November 9, 2015	EX-3.1	AMENDED AND RESTATED BYLAWS OMEGA PROTEIN CORPORATION, a Nevada corporation (AMENDED THROUGH NOVEMBER 5, 2015) ARTICLE I STOCKHOLDERS’ MEETING ex3-1.htm Exhibit 3.1 AMENDED AND RESTATED BYLAWS OMEGA PROTEIN CORPORATION, a Nevada corporation (AMENDED THROUGH NOVEMBER 5, 2015) ARTICLE I STOCKHOLDERS’ MEETING Section 1.1 Place of Meetings. All meetings of the stockholders shall be held at the principal office of Omega Protein Corporation (the “Corporation”) in the State of Texas (“Principal Office”), or at any other place within or without
November 9, 2015	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits ome201511048k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada 001-14003 76-0562134 (State or other jurisdiction of incorpo
November 4, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to . Commission file number: 001-14003 OMEGA PROT
November 4, 2015	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201510308k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): November 4, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission
November 4, 2015	EX-99.1	Omega Protein Announces Third Quarter 2015 Financial Results EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Omega Protein Announces Third Quarter 2015 Financial Results HOUSTON, TX – November 4, 2015 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils, essential fatty acids and specialty protein products, today reported financial results for the third quarter ended September 30, 2015. Thi
October 8, 2015	SC 13D/A	OME / Omega Protein Corp. / WYNNEFIELD PARTNERS SMALL CAP VALUE LP I - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 1) Under the Securities Exchange Act of 1934 OMEGA PROTEIN CORPORATION ‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ (Name of Issuer) Common Stock, $0.01 par value ‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾
September 25, 2015	8-K	Financial Statements and Exhibits, Other Events ome201509248k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): September 25, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commissio
September 25, 2015	EX-99.1	Omega Protein Announces Review of Strategic Alternatives ex99-1.htm Exhibit 99.1 Omega Protein Announces Review of Strategic Alternatives HOUSTON, September 25, 2015 - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils, essential fatty acids and specialty protein products, announced that its Board of Directors is in the process of a review of strategic alternatives to enhance sharehol
September 17, 2015	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201509158k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): September 17, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commissio
September 17, 2015	EX-99.1	EX-99.1 EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Exhibit 99.1
September 16, 2015	SC 13D/A	OME / Omega Protein Corp. / Schechter Joshua - AMENDMENT NO. 1 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 Omega Protein Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 68210P107 (CUSIP Number) JOSHUA E. SC
September 1, 2015	EX-10.1	EMPLOYMENT AGREEMENT ex10-1.htm Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement dated and effective as of August 31, 2015, 2015 (this "Agreement") is entered into by and between Omega Protein Corporation, a Nevada corporation with headquarters in Houston, Texas (the "Company" or "Omega"), and Mark Livingston (the "Employee"). WHEREAS, the Company desires to employ the Employee on the terms and conditions s
September 1, 2015	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201508288k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): August 31, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission F
September 1, 2015	EX-10.2	OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN ex10-2.htm Exhibit 10.2 OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN (Employee) In this Award, Omega Protein Corporation (the ?Company?) grants to Mark Livingston (the ?Participant?), an Employee, Restricted Stock under the Omega Protein Corporation 2015 Long Term Incentive Plan (the ?Plan?) as of the Date of Grant written below. This Award of Restricted
August 24, 2015	EX-10.8	AMENDED AND RESTATED SWINGLINE NOTE Exhibit 10.8 AMENDED AND RESTATED SWINGLINE NOTE $10,000,000.00 August 20, 2015 FOR VALUE RECEIVED, OMEGA PROTEIN CORPORATION, a Nevada corporation, and OMEGA PROTEIN, INC., a Virginia corporation, each having its principal place of business at 2105 Citywest Blvd., Suite 500, Houston, Texas 77042 (collectively, the ?Borrowers?), jointly and severally promise to pay to the order of WELLS FARGO BANK
August 24, 2015	EX-10.4	AMENDED AND RESTATED REVOLVING CREDIT NOTE (REVOLVING A LOANS) Exhibit 10.4 AMENDED AND RESTATED REVOLVING CREDIT NOTE (REVOLVING A LOANS) $30,400,000.00 August 20, 2015 FOR VALUE RECEIVED, OMEGA PROTEIN CORPORATION, a Nevada corporation, and OMEGA PROTEIN, INC., a Virginia corporation, each having its principal place of business at 2105 Citywest Blvd., Suite 500, Houston, Texas 77042 (collectively, the ?Borrowers?), jointly and severally promise to pay to th
August 24, 2015	EX-10.5	REVOLVING CREDIT NOTE (REVOLVING B LOANS) Exhibit 10.5 REVOLVING CREDIT NOTE (REVOLVING B LOANS) $9,600,000.00 August 20, 2015 FOR VALUE RECEIVED, OMEGA PROTEIN CORPORATION, a Nevada corporation, OMEGA PROTEIN, INC., a Virginia corporation, each having its principal place of business at 2105 Citywest Blvd., Suite 500, Houston, Texas 77042, and BIORIGINAL FOOD & SCIENCE CORP., a corporation amalgamated under the laws of Saskatchewan, havin
August 24, 2015	EX-10.9	SECOND AMENDED AND RESTATED GUARANTY AGREEMENT EX-10.9 10 ex10-9.htm EXHIBIT 10.9 Exhibit 10.9 SECOND AMENDED AND RESTATED GUARANTY AGREEMENT THIS SECOND AMENDED AND RESTATED GUARANTY AGREEMENT, dated as of August 20, 2015 (together with any amendments or supplements hereto, this “Guaranty Agreement”), by PROTEIN FINANCE COMPANY, a Delaware corporation, OMEGA SHIPYARD, INC., a Delaware corporation, PROTEIN INDUSTRIES, INC., a Delaware corporat
August 24, 2015	EX-10.1	$125,000,000.00 SECOND AMENDED AND RESTATED LOAN AGREEMENT dated as of August 20, 2015, by and among OMEGA PROTEIN CORPORATION, OMEGA PROTEIN, INC. and BIORIGINAL FOOD & SCIENCE CORP., each as a Borrower, the Lenders referred to herein, as Lenders, a ex10-1.htm Exhibit 10.1 $125,000,000.00 SECOND AMENDED AND RESTATED LOAN AGREEMENT dated as of August 20, 2015, by and among OMEGA PROTEIN CORPORATION, OMEGA PROTEIN, INC. and BIORIGINAL FOOD & SCIENCE CORP., each as a Borrower, the Lenders referred to herein, as Lenders, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, Swingline Lender and Issuing Lender WELLS FARGO SECURITIES
August 24, 2015	EX-10.2	SECOND AMENDED AND RESTATED REVOLVING CREDIT NOTE (REVOLVING A LOANS) ex10-2.htm Exhibit 10.2 SECOND AMENDED AND RESTATED REVOLVING CREDIT NOTE (REVOLVING A LOANS) $45,600,000.00 August 20, 2015 FOR VALUE RECEIVED, OMEGA PROTEIN CORPORATION, a Nevada corporation, and OMEGA PROTEIN, INC., a Virginia corporation, each having its principal place of business at 2105 Citywest Blvd., Suite 500, Houston, Texas 77042 (collectively, the “Borrowers”), jointly and severally pr
August 24, 2015	EX-99.1	Omega Protein Enters Into New $125 Million Revolving Credit Facility Exhibit 99.1 Omega Protein Enters Into New $125 Million Revolving Credit Facility HOUSTON, TX ? August 24, 2015 ? Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils, essential fatty acids and specialty protein products, announced today that it has entered into a new $125 million revolving credit agreement, which matures in August
August 24, 2015	EX-10.7	REVOLVING CREDIT NOTE (REVOLVING B LOANS) EX-10.7 8 ex10-7.htm EXHIBIT 10.7 Exhibit 10.7 REVOLVING CREDIT NOTE (REVOLVING B LOANS) $6,000,000.00 August 20, 2015 FOR VALUE RECEIVED, OMEGA PROTEIN CORPORATION, a Nevada corporation, OMEGA PROTEIN, INC., a Virginia corporation, each having its principal place of business at 2105 Citywest Blvd., Suite 500, Houston, Texas 77042, and BIORIGINAL FOOD & SCIENCE CORP., a corporation amalgamated und
August 24, 2015	EX-10.6	REVOLVING CREDIT NOTE (REVOLVING A LOANS) EX-10.6 7 ex10-6.htm EXHIBIT 10.6 Exhibit 10.6 REVOLVING CREDIT NOTE (REVOLVING A LOANS) $19,000,000.00 August 20, 2015 FOR VALUE RECEIVED, OMEGA PROTEIN CORPORATION, a Nevada corporation, and OMEGA PROTEIN, INC., a Virginia corporation, each having its principal place of business at 2105 Citywest Blvd., Suite 500, Houston, Texas 77042 (collectively, the “Borrowers”), jointly and severally promise
August 24, 2015	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): August 20, 2015 Omega Protein Corporation ome201508198k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): August 20, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada 001-14003 76-0562134 (State or other jurisdiction of incorporation) (C
August 24, 2015	EX-10.3	REVOLVING CREDIT NOTE (REVOLVING B LOANS) Exhibit 10.3 REVOLVING CREDIT NOTE (REVOLVING B LOANS) $14,400,000.00 August 20, 2015 FOR VALUE RECEIVED, OMEGA PROTEIN CORPORATION, a Nevada corporation, OMEGA PROTEIN, INC., a Virginia corporation, each having its principal place of business at 2105 Citywest Blvd., Suite 500, Houston, Texas 77042, and BIORIGINAL FOOD & SCIENCE CORP., a corporation amalgamated under the laws of Saskatchewan, havi
August 12, 2015	SC 13D	OME / Omega Protein Corp. / Schechter Joshua - SCHEDULE 13D Activist Investment SC 13D 1 sc13d0907600908062015.htm SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 Omega Protein Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Se
August 12, 2015	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.01 par value, of Omega Protein Corporation, a Nevada corporation. This J
August 11, 2015	SC 13D	OME / Omega Protein Corp. / WYNNEFIELD PARTNERS SMALL CAP VALUE LP I - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 OMEGA PROTEIN CORPORATION ‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ (Name of Issuer) Common Stock, $0.01 par value ‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾
August 11, 2015	EX-99.1	SCHEDULE 13D JOINT FILING AGREEMENT EXHIBIT 1 SCHEDULE 13D JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13D (the “Schedule 13D”) with respect to the common stock of Omega Protein Corporation, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.
August 11, 2015	8-K	Financial Statements and Exhibits, Other Events ome201508118k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): August 11, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission F
August 11, 2015	EX-99.1	Omega Protein Receives Letter from Shareholder ex99-1.htm Exhibit 99.1 Omega Protein Receives Letter from Shareholder HOUSTON, August 11, 2015 - Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils, essential fatty acids and specialty protein products, acknowledged today that it has received a letter from a shareholder, Wynnefield Capital Management, LLC that was filed as an e
August 5, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to . Commission file number: 001-14003 OMEGA PROTEIN C
August 5, 2015	EX-99.1	Omega Protein Announces Second Quarter 2015 Financial Results ex99-1.htm Exhibit 99.1 Omega Protein Announces Second Quarter 2015 Financial Results HOUSTON, TX ? August 5, 2015 ? Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils, essential fatty acids and specialty protein products, today reported financial results for the second quarter ended June 30, 2015. Second Quarter Highlights ? Rev
August 5, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition ome201507288k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): August 5, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fi
August 5, 2015	EX-3.1	AMENDED AND RESTATED BYLAWS OMEGA PROTEIN CORPORATION, a Nevada corporation (AMENDED THROUGH AUGUST 4, 2015) ARTICLE I STOCKHOLDERS’ MEETING ex3-1.htm EXHIBIT 3.1 AMENDED AND RESTATED BYLAWS OMEGA PROTEIN CORPORATION, a Nevada corporation (AMENDED THROUGH AUGUST 4, 2015) ARTICLE I STOCKHOLDERS’ MEETING Section 1.1 Place of Meetings. All meetings of the stockholders shall be held at the principal office of the corporation in the State of Texas (“Principal Office”), or at any other place within or without the State of Nevada as may be de
June 30, 2015	EX-10.1	OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN (Independent Director) ex10-1.htm Exhibit 10.1 OMEGA PROTEIN CORPORATION AWARD OF RESTRICTED STOCK UNDER 2015 LONG TERM INCENTIVE PLAN (Independent Director) In this Award, Omega Protein Corporation (the ?Company?) grants to (the ?Participant?), a Director, Restricted Stock under the Omega Protein Corporation 2015 Long Term Incentive Plan (the ?Plan?) as of the Date of Grant written below. This Award of Restricted Stock
June 30, 2015	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201506308k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): June 25, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fil
June 23, 2015	S-8	Omega Protein FORM S-8 ome20150529_s8.htm As filed with the Securities and Exchange Commission on June 23, 2015. Registration No. 333-_ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 omega protein corporation (Exact name of registrant as specified in its charter) Nevada (State or Other Jurisdiction of Incorporation or Organization)
May 19, 2015	EX-99.1	EX-99.1 Exhibit 99.1
May 19, 2015	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 ome201505188k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 19, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (
May 11, 2015	8-K	Omega Protein FORM 8-K (Current Report/Significant Event) ome201505118k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): May 11, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission File
May 11, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to . Commission file number: 001-14003 OMEGA PROTEIN
May 11, 2015	EX-99.1	Omega Protein Announces First Quarter 2015 Financial Results ex99-1.htm Exhibit 99.1 Omega Protein Announces First Quarter 2015 Financial Results HOUSTON, TX – May 11, 2015 – Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils, essential fatty acids and specialty protein products, today reported financial results for the first quarter ended March 31, 2015. First Quarter Highlights ● Revenue
April 29, 2015	DEF 14A	Omega Protein FORM DEF 14A ome20150330def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Pro
March 11, 2015	EX-10.64	EMPLOYMENT AGREEMENT Exhibit 10.64 EMPLOYMENT AGREEMENT THIS AGREEMENT made as of the 1st day of April 2013 ("Effective Date"). BETWEEN: BIORIGINAL FOOD & SCIENCE CORP. Herein called "Bioriginal" or the "Corporation" AND: JOE REINHARD HERMAN VIDAL Herein called "Vidal" WHEREAS Vidal has served Bioriginal as an officer of the corporation since February 1, 1999; AND WHEREAS the parties wish to set out in writing their a
March 11, 2015	EX-10.63	EMPLOYMENT AGREEMENT Exhibit 10.63 EMPLOYMENT AGREEMENT This Employment Agreement dated and effective as of March 10, 2015 (this "Agreement") is entered into by and between Omega Protein Corporation, a Nevada corporation with headquarters in Houston, Texas (the "Company" or "Omega"), and Montgomery Deihl (the "Employee"). WHEREAS, the Company desires to employ the Employee on the terms and conditions set forth herein;
March 11, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition ome201503108k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): March 11, 2015 Omega Protein Corporation (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 001-14003 (Commission Fi
March 11, 2015	EX-10.62	RENTAL AGREEMENT BOSLAND 40 DEN BOMMEL ex10-62.htm Exhibit 10.62 RENTAL AGREEMENT BOSLAND 40 DEN BOMMEL RENTAL AGREEMENT OFFICE SPACE and other business space within the meaning of article 7:2:30a of the Dutch Civil Code Model by the Real Estate Council (ROZ) adopted on July 30, 2003. Reference to this model and its use is only permitted if completed, added or different text is clearly recognizable as such. Additions and variations sho
March 11, 2015	EX-10.26	SECOND AMENDMENT TO LEASE AGREEMENT (BUILDING 3) Exhibit 10.26 SECOND AMENDMENT TO LEASE AGREEMENT (BUILDING 3) This Second Amendment to Lease Agreement (this “Amendment”) is entered into as of December 19, 2014 (the “Effective Date”) by and between PKY-2101 CITYWEST 3 & 4, L.P., a Delaware limited partnership (herein referred to as “Landlord”), as landlord, and OMEGA PROTEIN CORPORATION, a Nevada corporation (herein referred to as “Tenant”), as
March 11, 2015	EX-21	Omega Protein Corporation owns 100% of the common stock of: Exhibit 21 Omega Protein Corporation owns 100% of the common stock of: ? Protein Finance Company, a Delaware corporation ? Omega Shipyard, Inc.
March 11, 2015	EX-99.1	Omega Protein Announces Fourth Quarter and Full Year 2014 Financial Results ex99-1.htm Exhibit 99.1 Omega Protein Announces Fourth Quarter and Full Year 2014 Financial Results HOUSTON, TX ? March 11, 2015 ? Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils, essential fatty acids and specialty protein products, today reported financial results for the fourth quarter and year ended December 31, 2014. Four
March 11, 2015	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-14003 OMEGA PROTEIN CORPORATION

OME / Omega Protein Corp. - Документы SEC, Годовой отчет, Доверенное заявление

Основная статистика

SEC Filings

SEC Filings (Chronological Order)